Price T Rowe Associates Inc Trevena Inc Transaction History

Price T Rowe Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.2 - $0.5 $2,842 - $7,106	-14,212 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.41 - $0.63 $1,640 - $2,520	4,000 Added 39.17%	14,212 $8,000
Q4 2021 Feb 14, 2022	SELL	$0.57 - $1.29 $1,994 - $4,515	-3,500 Reduced 25.53%	10,212 $6,000
Q2 2021 Aug 16, 2021	BUY	$1.46 - $2.25 $20,019 - $30,852	13,712 New	13,712 $23,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $295M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.